Wall Street’s Key Stock Analysts Research Report

Wall Street’s Key Stock Analysts Research Report

$BUD, $CMCSA, $JAZZ, $KBH, $KMI, $NLTX

Daily HeffX-LTN reviews dozens of  Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is the list for Friday, 13 March, as follows:

Anheuser-Busch InBev S.A./N.V. (NYSE:BUD) was raised to Outperform from Sector Perform at RBC Capital Markets, with the firm citing excess share price weakness and its aggressive debt reduction efforts

Comcast Corp. (NASDAQ:CMCSA) was maintained as Overweight at KeyBanc Capital Markets, but the target price was lowered to 46 from 50 in the call.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) was raised to Outperform from Market Perform but its target price was lowered to 166 from 175 at Bernstein.

KB Home (NYSE:KBH) was raised to Buy from Neutral at BofA Securities, but the firm lowered its price target to 36 from 44.

Kinder Morgan Inc. (NYSE:KMI) was raised to Outperform from Market Perform at Raymond James.

Neoleukin Therapeutics Inc. (NASDAQ:NLTX) was started with a Buy rating and a 20 target price at Canaccord Genuity

Have a terrific weekend

The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.

Latest posts by HEFFX Australia (see all)